China Universal Asset Management Co., Ltd.
Position in NBP — NovaBridge Biosciences
CIK 1906594
SHANGHAI, F4
Position in NBP
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$34,834
-$14,166 QoQ
Shares Held
17,864
-10.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 3 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $180,189,557 across 240 Biotechnology names. NBP ranks #213 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
48,265 | $23,974,673 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,498 | $12,157,782 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,269 | $7,606,727 | |
| 4 | RPRX |
Royalty Pharma plc
|
120,547 | $6,759,070 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
33,835 | $6,336,618 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
76,302 | $6,049,985 | |
| 7 | MRNA |
Moderna, Inc.
|
63,149 | $4,422,324 | |
| 8 | ARGX |
Argenx SE
|
4,642 | $4,306,708 |
All Filings in NBP
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,834 | 17,864 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $49,000 | 19,919 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $67,421 | 16,940 | Shares | Sole | 2026-01-29 | |
| 2023-09-30 | $2,361 | 1,789 | Shares | Sole | 2024-05-22 | |
| 2023-06-30 | $2,699 | 903 | Shares | Sole | 2024-05-22 | |
| 2023-03-31 | $3,200 | 925 | Shares | Sole | 2024-05-22 | |
| 2022-12-31 | $2,311 | 553 | Shares | Sole | 2024-05-22 | |
| 2022-09-30 | $1,992 | 497 | Shares | Sole | 2022-10-21 | |
| No filing history on record for this holder in this stock. | ||||||